Skip to main content
Log in

A rare cause of acute kidney injury with chronic myelomonocytic leukemia

  • Case Report
  • Published:
CEN Case Reports Aims and scope Submit manuscript

Abstract

An 80-year-old man with myelodysplastic syndrome developed acute kidney injury (AKI) and peripheral blood monocyte-dominant leukocytosis. Glomerular disease was suspected from urinalysis, which showed proteinuria and microscopic hematuria with red cell casts. Eventually, he died of respiratory failure, after which a postmortem was performed. In the glomeruli, the extracapillary space was filled with numerous mononuclear cells and erythrocytes. At first interpretation, the glomerular findings appeared to represent cellular crescents. However, immunostaining revealed that the extracapillary mononuclear cells were in fact leukemic cells. Furthermore, tubular injury due to marked accumulation of lysozyme was also recognized together with infiltration of leukemic cells in the interstitium. The diagnosis of kidney infiltration by chronic myelomonocytic leukemia (CMML) and lysozyme-induced tubular injury was eventually made. Our case is the first report showing extracapillary infiltration of leukemic cells by immunostaining. In addition, lysozyme-induced tubular injury is a forgotten cause of kidney injury in patients with CMML. This case teaches us the rare and forgotten causes of AKI with CMML.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–405. https://doi.org/10.1182/blood-2016-03-643544.

    Article  CAS  Google Scholar 

  2. Patnaik MM, Tefferi A. Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management. Am J Hematol. 2018;93(6):824–40. https://doi.org/10.1002/ajh.25104.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Patel TV, Rennke HG, Sloan JM, DeAngelo DJ, Charytan DM. A forgotten cause of kidney injury in chronic myelomonocytic leukemia. Am J Kidney Dis. 2009;54(1):159–64. https://doi.org/10.1053/j.ajkd.2008.11.013.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Hillen JM, Raemaekers JM, Steenbergen EJ, Wetzels JFM, Verhave JC. Progressive kidney failure in chronic myelomonocytic leukaemia: don’t forget lysozyme damage. Netherlands J Med. 2018;76(9):407–10.

    CAS  Google Scholar 

  5. Robinet-Zimmermann G, Rioux-Leclercq N, Frouget T, Le Naoures C. Lysozyme-induced nephropathy: a rare cause of renal failure in chronic myelomonocytic leukemia. Ann Pathol. 2020. https://doi.org/10.1016/j.annpat.2020.04.001.

    Article  PubMed  Google Scholar 

  6. Santoriello D, Andal LM, Cox R, D’Agati VD, Markowitz GS. Lysozyme-Induced Nephropathy. Kidney Int Rep. 2017;2(1):84–8. https://doi.org/10.1016/j.ekir.2016.09.002.

    Article  PubMed  Google Scholar 

  7. Robinson GT, Sundaram KR, Dilly SA, Bevan DH, Andrews PA. Renal failure in a patient with chronic myelomonocytic leukaemia. Nephrol Dialysis Trans. 1997;12(7):1500–2. https://doi.org/10.1093/ndt/12.7.1500.

    Article  CAS  Google Scholar 

  8. Spapen J, Fostier K, De Raeve H, Janssens P, Spapen H. An unexpected complication of chronic myelomonocytic leukemia: severe renal failure due to malignant tubulo-interstitial cell infiltration. Int J Nephrol Renovasc Dis. 2016;9:1–4. https://doi.org/10.2147/IJNRD.S98528.

    Article  PubMed  Google Scholar 

  9. Enriquez R, Sirvent AE, Marin F, Perez M, Alpera MR, Amoros F. Severe renal complications in chronic myelomonocytic leukemia. J Nephrol. 2008;21(4):609–14.

    CAS  PubMed  Google Scholar 

  10. Morschhauser F, Wattel E, Pagniez D, Lovi V, Rose C, Bauters F, et al. Glomerular injury in chronic myelomonocytic leukemia. Leukemia lymphoma. 1995;18(5–6):479–83. https://doi.org/10.3109/10428199509059648.

    Article  CAS  PubMed  Google Scholar 

  11. Luciano RL, Brewster UC. Kidney involvement in leukemia and lymphoma. Adv Chronic Kidney Dis. 2014;21(1):27–35. https://doi.org/10.1053/j.ackd.2013.07.004.

    Article  PubMed  Google Scholar 

  12. Said SM, Leung N, Sethi S, Cornell LD, Fidler ME, Grande JP, et al. Myeloproliferative neoplasms cause glomerulopathy. Kidney Int. 2011;80(7):753–9. https://doi.org/10.1038/ki.2011.147.

    Article  PubMed  Google Scholar 

  13. Osserman EF, Lawlor DP. Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J Exp Med. 1966;124(5):921–52. https://doi.org/10.1084/jem.124.5.921.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Pruzanski W, Platts ME. Serum and urinary proteins, lysozyme (muramidase), and renal dysfunction in mono- and myelomonocytic leukemia. J Clin Invest. 1970;49(9):1694–708. https://doi.org/10.1172/JCI106387.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marina Asano.

Ethics declarations

Conflict of interest

All the authors have declared no competing interest.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Asano, M., Hase, H., Naruse, Y. et al. A rare cause of acute kidney injury with chronic myelomonocytic leukemia. CEN Case Rep 10, 320–325 (2021). https://doi.org/10.1007/s13730-020-00567-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13730-020-00567-6

Keywords

Navigation